What We're Reading: Page 223
Industry reads hand-picked by our editors
Nov 26, 2019
-
Bloomberg
HLB's Cancer Drug Won Plaudits But There Was No Award
-
Reuters
Blackstone to invest $400 million in gene therapy venture with Ferring
-
Financial Times
South Korea’s SK Biopharmaceuticals plans to raise $850m in IPO
-
Endpoints News
Ex-Purdue CEO stands to earn a huge windfall in Novartis' buyout of the Medicines Co
Nov 25, 2019
Nov 22, 2019
-
STAT
Gene therapy pioneer: Field is behind, and delivery tech is 'embarrassing'
-
Bloomberg
Sanofi Is Said to Mull Options for $30 Billion Consumer Arm
-
Reuters
Oklahoma to seek billions more from J&J over opioid crisis on appeal
-
The San Diego Union-Tribune
Union-Tribune biotech writer Bradley J. Fikes, beloved by colleagues, dies at 62
Nov 21, 2019
-
MIT Technology Review
A giant, superfast AI chip is being used to find better cancer drugs
-
Puget Sound Business Journal
Seattle Genetics CEO wants his company to be the face of area's biotech scene
-
Reuters
Charity to pay $4 million to resolve U.S. pharma kickback probe
-
Gizmodo
It's time to kick big pharma out of antibiotics research, scientists argue
Nov 20, 2019
-
The Wall Street Journal
Generic-Drug Approvals Soar, But Patients Still Go Without
-
Associated Press
OxyContin maker thrives in China with abandoned US tactics
-
Ventura County Star
Thousand Oaks-based biotech company Amgen eliminating jobs
Previous
